Erratum: "Intranasal administration of the growth-compromised HSV-2 vector ΔRR prevents kainate-induced seizures and neuronal loss in rats and mice" (Molecular Therapy (2006) vol. 13 (870-881) 10.1016/j.ymthe.2005.12.013);Intranasal Administration of the Growth-Compromised HSV-2 Vector ΔRR Prevents Kainate-Induced Seizures and Neuronal Loss in Rats and Mice

Molecular Therapy

Volumn 13, Issue 5, 2006, Pages 870-881

  Laing, Jennifer M ^a   Gober, Michael D ^a   Golembewski, Erin K ^a   Thompson, Scott M ^a   Gyure, Kymberly A ^a   Yarowsky, PaulJ ^a   Aurelian, Laure ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

gene therapy; glia; HSV; ICP10PK; kainic acid; neuroprotection; seizures

Indexed keywords

INFECTED CELL PROTEIN 10 PROTEIN KINASE; KAINIC ACID; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HERPES SIMPLEX VIRUS 2; HIPPOCAMPUS; HUMAN; HUMAN CELL; MALE; MOUSE; NERVE CELL DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIMARY PREVENTION; RAT; SEIZURE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS MUTANT; VIRUS REPLICATION;

ANIMALIA; HUMAN HERPESVIRUS 2;

EID: 33645889324     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300211     Document Type: Erratum

References (39)

1. Natsume A., et al. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. Exp. Neurol. 169 (2001) 231-238
2. Kalwy S.A., Akbar M.T., Coffin R.S., de Belleroche J., and Latchman D.S. Heat shock protein 27 delivered via a herpes simplex virus vector can protect neurons of the hippocampus against kainic-acid-induced cell loss. Brain Res. Mol. Brain Res. 111 (2003) 91-103
3. Najioullah F., et al. Diagnosis and surveillance of herpes simplex virus infection of the central nervous system. J. Med. Virol. 61 (2000) 468-473
4. Perkins D., Gyure K.A., Pereira E.F., and Aurelian L. Herpes simplex virus type 1-induced encephalitis has an apoptotic component associated with activation of c-Jun N-terminal kinase. J. Neurovirol. 9 (2003) 101-111
5. Perkins D., Pereira E.F., and Aurelian L. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1. J. Virol. 77 (2003) 1292-1305
6. Wu H.M., et al. Herpes simplex virus type 1 inoculation enhances hippocampal excitability and seizure susceptibility in mice. Eur. J. Neurosci. 18 (2003) 3294-3304
7. Olschowka J.A., Bowers W.J., Hurley S.D., Mastrangelo M.A., and Federoff H.J. Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS. Mol. Ther. 7 (2003) 218-227
8. Monville C., et al. HSV vector-delivery of GDNF in a rat model of PD: partial efficacy obscured by vector toxicity. Brain Res. 1024 (2004) 1-15
9. Goldstein D.J., and Weller S.K. Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant. Virology 166 (1988) 41-51
10. Gähwiler B.H., Capogna M., Debanne D., McKinney R.A., and Thompson S.M. Organotypic slice cultures: a technique has come of age. Trends Neurosci. 20 (1997) 471-477
11. Smith C.C., Peng T., Kulka M., and Aurelian L. The PK domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for immediate-early gene expression and virus growth. J. Virol. 72 (1998) 9131-9141
12. Tomlinson A.H., and Esiri M.M. Herpes simplex encephalitis: immunohistological demonstration of spread of virus via olfactory pathways in mice. J. Neurol. Sci. 60 (1983) 473-484
13. Kandel E.R. Learning and memory. In: Kandel E.R., Schwartz J.H., and Jessell T.M. (Eds). Principles of Neural Science. 4th ed. (2000), McGraw-Hill, New York 1227-1246
14. Roizman B., and Sears A.E. Herpes simplex viruses and their replication. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Virology. 3rd ed. (1996), Lippincott-Raven Publishers, Philadelphia 2231-2295
15. Sourisseau T., et al. Alteration of the stability of Bag-1 protein in the control of olfactory neuronal apoptosis. J. Cell Sci. 114 (2001) 1409-1416
16. Ben-Ari Y., and Cossart R. Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci. 22 (2000) 580-587
17. Sperk G., Lassmann H., Baran H., Kish S.J., Seitelberger F., and Hornykiewicz O. Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience 10 (1983) 1301-1315
18. Hu R.Q., Koh S., Torgerson T., and Cole A.J. Neuronal stress and injury in C57/BL mice after systemic kainic acid administration. Brain Res. 810 (1998) 229-240
19. Chen Z., et al. Increased microglial activation and astrogliosis after intranasal administration of kainic acid in C57BL/6 mice. J. Neurobiol. 62 (2005) 207-218
20. Wang Q., Yu S., Simonyi A., Sun G.Y., and Sun A.Y. Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Mol. Neurobiol. 31 (2005) 3-16
21. Penkowa M., et al. Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures. J. Neurosci. Res. 79 (2005) 522-534
22. Little A.R., and O'Callaghan J.P. Astrogliosis in the adult and developing CNS: is there a role for proinflammatory cytokines?. Neurotoxicology 22 (2001) 607-618
23. Smith C.C., Nelson J., Aurelian L., Gober M., and Goswami B.B. Ras-GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth. J. Virol. 74 (2000) 10417-10429
24. Zhu J., and Aurelian L. AP-1 cis-response elements are involved in basal expression and Vmw110 transactivation of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). Virology 231 (1997) 301-312
25. Gober M.D., Wales S.Q., Hunter J.C., Sharma B.K., and Aurelian L. Stress upregulates neuronal expression of the HSV-2 large subunit of ribonucleotide reductase (R1; ICP10) by activating AP-1. J. Neurovirol. 11 (2005) 329-336
26. Smith C.C., and Aurelian L. The large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is associated with the virion tegument and has PK activity. Virology 234 (1997) 235-242
27. Sewards T.V., and Sewards M.A. Input and output stations of the entorhinal cortex: superficial vs. deep layers or lateral vs. medial divisions?. Brain Res. Brain Res. Rev. 42 (2003) 243-251
28. Thorne R.G., Pronk G.J., Padmanabhan V., and Frey II W.H. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127 (2004) 481-496
29. Carbonell W.S., Murase S., Horwitz A.F., and Mandell J.W. Migration of perilesional microglia after focal brain injury and modulation by CC chemokine receptor 5: an in situ time-lapse confocal imaging study. J. Neurosci. 25 (2005) 7040-7047
30. Frenkel D., and Solomon B. Filamentous phage as vector-mediated antibody delivery to the brain. Proc. Natl. Acad. Sci. USA 99 (2002) 5675-5679
31. Elliott G., and O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88 (1997) 223-233
32. Cashman S.M., Sadowski S.L., Morris D.J., Frederick J., and Kumar-Singh R. Intercellular trafficking of adenovirus-delivered HSV VP22 from the retinal pigment epithelium to the photoreceptors-Implications for gene therapy. Mol. Ther. 6 (2002) 813-823
33. Milatovic D., Gupta R.C., and Dettbarn W.D. Involvement of nitric oxide in kainic acid-induced excitotoxicity in rat brain. Brain Res. 957 (2002) 330-337
34. Aurelian L. HSV-induced apoptosis in herpes encephalitis. Curr. Top. Microbiol. Immunol. 289 (2005) 79-111
35. Shinoda S., et al. Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1 during seizure-induced neuronal death. Eur. J. Neurosci. 17 (2003) 2065-2076
36. Pennypacker K.R., Thai L., Hong J.S., and McMillian M.K. Prolonged expression of AP-1 transcription factors in the rat hippocampus after systemic kainate treatment. J. Neurosci. 14 (1994) 3998-4006
37. Ahn K., et al. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 15 (1996) 3247-3255
38. Salio M., Cella M., Suter M., and Lanzavecchia A. Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 29 (1999) 3245-3253
39. Perkins D., Pereira E.F., Gober M., Yarowsky P.J., and Aurelian L. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway. J. Virol. 76 (2002) 1435-1449